Skip to main content

and
  1. Article

    Open Access

    Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status

    It has been observed that ras-transformed cell lines in culture have a higher phosphatidylcholine (PC) biosynthesis rate as well as higher PC-degradation rate (increased PC-turnover) than normal cells. In corr...

    Lenka A. Taylor, Jann Arends, Arwen K. Hodina in Lipids in Health and Disease (2007)

  2. No Access

    Article

    Marine phospholipids—a promising new dietary approach to tumor-associated weight loss

    Advanced tumor disease very often evokes excessive loss of body weight. Among others, fish oil or marine fatty acid ethyl esters were investigated for treatment of cancer cachexia with controversial results. I...

    Lenka A. Taylor, Lars Pletschen, Jann Arends, Clemens Unger in Supportive Care in Cancer (2010)

  3. No Access

    Article

    Understanding the mechanisms and treatment options in cancer cachexia

    Cancer cachexia is a metabolic syndrome that is defined by loss of muscle mass. This syndrome can cause a great deal of distress to patients with cancer and their families. This Review article outlines the sym...

    Kenneth Fearon, Jann Arends, Vickie Baracos in Nature Reviews Clinical Oncology (2013)

  4. No Access

    Article

    Quality of care for cancer patients on home parenteral nutrition: development of key interventions and outcome indicators using a two-round Delphi approach

    Clear recommendations on how to guide patients with cancer on home parenteral nutrition (HPN) are lacking as the use of HPN in this population remains a controversial issue. Therefore, the aims of this study w...

    Mira Dreesen, Veerle Foulon, Martin Hiele, Kris Vanhaecht in Supportive Care in Cancer (2013)

  5. No Access

    Book

    Kachexie bei Tumorerkrankungen

    Erkennen und multimodal behandeln

    Jann Arends, Ulrich Hacker, David Blum (2018)

  6. No Access

    Chapter

    Ernährungstherapie bei Tumorkachexie

    Bei sehr weit fortgeschrittener Tumorerkrankung und erkennbarem Eintritt in die letzten Lebenswochen und -tage steht das Stillen von Hunger und Durst im Vordergrund. In allen anderen Fällen ist die Behandlung ...

    Jann Arends in Kachexie bei Tumorerkrankungen (2018)

  7. No Access

    Chapter

    Multimodale Therapie bei Tumorkachexie

    Aufgrund der komplexen und multifaktoriellen Pathogenese des Syndroms der Tumorkachexie sollten wirksame Behandlungsansätze sinnvollerweise kombiniert werden, wofür Kenneth Fearon das Konzept eines multimodale...

    Jann Arends, David Blum in Kachexie bei Tumorerkrankungen (2018)

  8. Article

    Correction to: Enteral and parenteral nutrition in cancer patients, a comparison of complication rates: an updated systematic review and (cumulative) meta-analysis

    The appendices were incorrectly numbered in the original article. Please see below correcct appendices

    Ronald Chow, Eduardo Bruera, Jann Arends, Declan Walsh in Supportive Care in Cancer (2020)

  9. No Access

    Article

    Enteral and parenteral nutrition in cancer patients, a comparison of complication rates: an updated systematic review and (cumulative) meta-analysis

    Weight loss in cancer patients is a worrisome constitutional change predicting disease progression and shortened survival time. A logical approach to counter some of the weight loss is to provide nutritional s...

    Ronald Chow, Eduardo Bruera, Jann Arends, Declan Walsh in Supportive Care in Cancer (2020)

  10. No Access

    Chapter

    COVID-19 in Patients with Cancer

    With more than 5 million cases and 333,212 deaths, COVID-19 (or SARS-CoV-2) continues to spread. General symptoms of this disease are similar to that of many other viral respiratory diseases, including fever, ...

    Ali Nowroozi, Sepideh Razi, Kamal Kant Sahu, Fabio Grizzi in Coronavirus Disease - COVID-19 (2021)

  11. No Access

    Living Reference Work Entry In depth

    Mangelernährung, Sarkopenie, Kachexie: Ursachen, Diagnostik, Therapie

    Die Nahrungsaufnahme ist bei Patienten mit fortgeschrittener Tumorerkrankung häufig reduziert und unzureichend. Der daraus resultierende Gewichts- und Zellverlust ist mit einer eingeschränkten Prognose, verrin...

    Jann Arends, Jürgen Körber in Kompendium Internistische Onkologie

  12. Article

    Open Access

    “Metabolic fingerprints” of cachexia in lung cancer patients

    Armin Frille, Jann Arends in European Journal of Nuclear Medicine and M… (2024)